{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T03:46:08Z","timestamp":1766807168898},"reference-count":31,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1253\/circj.cj-15-0104","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T22:07:02Z","timestamp":1432678022000},"page":"1733-1741","source":"Crossref","is-referenced-by-count":20,"title":["Clinical and Pathological Impact of Tissue Fibrosis on Lethal Arrhythmic Events in Hypertrophic Cardiomyopathy Patients With Impaired Systolic Function"],"prefix":"10.1253","volume":"79","author":[{"given":"Yuko","family":"Wada","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"},{"name":"Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Aiba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taka-aki","family":"Matsuyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikutaro","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Okamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Satomi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Radiology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Kanzaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Kusano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihisa","family":"Anzai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Kamakura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatsue","family":"Ishibashi-Ueda","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"},{"name":"Department of Cardiovascular Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Horie","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF\/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. <i>J Am Coll Cardiol<\/i> 2011; 58: e212\u2013e260, doi:10.1016\/j.jacc.2011.06.011.","DOI":"10.1016\/j.jacc.2011.06.011"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Davies MJ, McKenna WJ. Hypertrophic cardiomyopathy: Pathology and pathogenesis. <i>Histopathology<\/i> 1995; 26: 493\u2013500.","DOI":"10.1111\/j.1365-2559.1995.tb00267.x"},{"key":"3","unstructured":"3. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. <i>Lancet<\/i> 2012; 381: 242\u2013255."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Maron BJ, Rowin EJ, Casey SA, Haas TS, Chan RH, Udelson JE, et al. Risk stratification and outcome of patients with hypertrophic cardiomyopathy &gt;=60 years of age. <i>Circulation<\/i> 2013; 127: 585\u2013593.","DOI":"10.1161\/CIRCULATIONAHA.112.136085"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cripps TR, Counihan PJ, Frenneaux MP, Ward DE, Camm AJ, McKenna WJ. Signal-averaged electrocardiography in hypertrophic cardiomyopathy. <i>J Am Coll Cardiol<\/i> 1990; 15: 956\u2013961.","DOI":"10.1016\/0735-1097(90)90223-C"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM, et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. <i>J Am Coll Cardiol<\/i> 2010; 56: 875\u2013887.","DOI":"10.1016\/j.jacc.2010.05.007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hen Y, Iguchi N, Utanohara Y, Takada K, Machida H, Takayama M, et al. Prognostic value of late gadolinium enhancement on cardiac magnetic resonance imaging in japanese hypertrophic cardiomyopathy patients. <i>Circ J<\/i> 2014; 78: 929\u2013937.","DOI":"10.1253\/circj.CJ-13-0979"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Moon J, Hong YJ, Kim YJ, Shim CY, Jang Y, Chung N, et al. Extent of late gadolinium enhancement on cardiovascular magnetic resonance imaging and its relation to left ventricular longitudinal functional reserve during exercise in patients with hypertrophic cardiomyopathy. <i>Circ J<\/i> 2013; 77: 1742\u20131749.","DOI":"10.1253\/circj.CJ-12-1378"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. O\u2019Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. <i>J Am Coll Cardiol<\/i> 2010; 56: 867\u2013874.","DOI":"10.1016\/j.jacc.2010.05.010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Olivotto I, Cecchi F, Poggesi C, Yacoub MH. Patterns of disease progression in hypertrophic cardiomyopathy: An individualized approach to clinical staging. <i>Circ Heart Fail<\/i> 2012; 5: 535\u2013546.","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. <i>J Am Coll Cardiol<\/i> 2004; 43: 2260\u20132264.","DOI":"10.1016\/j.jacc.2004.03.035"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Moravsky G, Ofek E, Rakowski H, Butany J, Williams L, Ralph-Edwards A, et al. Myocardial fibrosis in hypertrophic cardiomyopathy: Accurate reflection of histopathological findings by CMR. <i>JACC Cardiovasc Imaging<\/i> 2013; 6: 587\u2013596.","DOI":"10.1016\/j.jcmg.2012.09.018"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Holzmann M, Nicko A, Kuhl U, Noutsias M, Poller W, Hoffmann W, et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: A retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. <i>Circulation<\/i> 2008; 118: 1722\u20131728.","DOI":"10.1161\/CIRCULATIONAHA.107.743427"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. <i>Circulation<\/i> 2014; 130: 484\u2013495.","DOI":"10.1161\/CIRCULATIONAHA.113.007094"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kono AK, Yamada N, Higashi M, Kanzaki S, Hashimura H, Morita Y, et al. Dynamic late gadolinium enhancement simply quantified using myocardium to lumen signal ratio: Normal range of ratio and diffuse abnormal enhancement of cardiac amyloidosis. <i>J Magn Reson Imaging<\/i> 2011; 34: 50\u201355.","DOI":"10.1002\/jmri.22602"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural (\u201csmall vessel\u201d) coronary artery disease in hypertrophic cardiomyopathy. <i>J Am Coll Cardiol<\/i> 1986; 8: 545\u2013557.","DOI":"10.1016\/S0735-1097(86)80181-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ. Hypertrophic cardiomyopathy: The interrelation of disarray, fibrosis, and small vessel disease. <i>Heart<\/i> 2000; 84: 476\u2013482.","DOI":"10.1136\/heart.84.5.476"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JAC. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. <i>J Am Coll Cardiol<\/i> 2011; 57: 891\u2013903.","DOI":"10.1016\/j.jacc.2010.11.013"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Goto D, Kinugawa S, Hamaguchi S, Sakakibara M, Tsuchihashi-Makaya M, Yokota T, et al. Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: Report from the registry data in Japan. <i>J Cardiol<\/i> 2012; 61: 65\u201370.","DOI":"10.1016\/j.jjcc.2012.08.010"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yilmaz A, Kindermann I, Kindermann M, Mahfoud F, Ukena C, Athanasiadis A, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: Differences in complication rate and diagnostic performance. <i>Circulation<\/i> 2010; 122: 900\u2013909.","DOI":"10.1161\/CIRCULATIONAHA.109.924167"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. <i>J Am Coll Cardiol<\/i> 2008; 51: 1369\u20131374.","DOI":"10.1016\/j.jacc.2007.11.071"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Varnava AM, Elliott PM, Mahon N, Davies MJ, McKenna WJ. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. <i>Am J Cardiol<\/i> 2001; 88: 275\u2013279.","DOI":"10.1016\/S0002-9149(01)01640-X"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: Preliminary validation in humans. <i>Circulation<\/i> 2010; 122: 138\u2013144.","DOI":"10.1161\/CIRCULATIONAHA.109.930636"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Zlochiver S, Munoz V, Vikstrom KL, Taffet SM, Berenfeld O, Jalife J. Electrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers. <i>Biophys J<\/i> 2008; 95: 4469\u20134480.","DOI":"10.1529\/biophysj.108.136473"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Schumacher B, Gietzen FH, Neuser H, Schummelfeder J, Schneider M, Kerber S, et al. Electrophysiological characteristics of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy and moderate to severe symptoms. <i>Circulation<\/i> 2005; 112: 2096\u20132101.","DOI":"10.1161\/CIRCULATIONAHA.104.515643"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Bongioanni S, Bianchi F, Migliardi A, Gnavi R, Pron PG, Casetta M, et al. Relation of QRS duration to mortality in a community-based cohort with hypertrophic cardiomyopathy. <i>Am J Cardiol<\/i> 2007; 100: 503\u2013506.","DOI":"10.1016\/j.amjcard.2007.03.049"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kamiyama N, Nezuo S, Sawayama T, Kawahara Y, Samukawa M, Suetuna R, et al. Electrocardiographic features differentiating dilated cardiomyopathy from hypertrophic cardiomyopathy. <i>J Electrocardiol<\/i> 1997; 30: 301\u2013306.","DOI":"10.1016\/S0022-0736(97)80042-8"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kawara T, Derksen R, de Groot JR, Coronel R, Tasseron S, Linnenbank AC, et al. Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. <i>Circulation<\/i> 2001; 104: 3069\u20133075.","DOI":"10.1161\/hc5001.100833"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. <i>JAMA<\/i> 2007; 298: 405\u2013412.","DOI":"10.1001\/jama.298.4.405"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ling LH, Kistler PM, Ellims AH, Iles LM, Lee G, Hughes GL, et al. Diffuse ventricular fibrosis in atrial fibrillation: Noninvasive evaluation and relationships with aging and systolic dysfunction. <i>J Am Coll Cardiol<\/i> 2012; 60: 2402\u20132408.","DOI":"10.1016\/j.jacc.2012.07.065"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Shirani J, Pick R, Roberts WC, Maron BJ. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. <i>J Am Coll Cardiol<\/i> 2000; 35: 36\u201344.","DOI":"10.1016\/S0735-1097(99)00492-1"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/advpub\/0\/advpub_CJ-15-0104\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T12:22:25Z","timestamp":1498220545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/8\/79_CJ-15-0104\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-15-0104","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}